Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 1
1995 2
1996 2
1997 3
1998 1
2003 1
2006 1
2007 1
2016 1
2017 1
2020 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants.
Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, Brough H, Marrs T, Radulovic S, Craven J, Flohr C, Lack G; EAT Study Team. Perkin MR, et al. N Engl J Med. 2016 May 5;374(18):1733-43. doi: 10.1056/NEJMoa1514210. Epub 2016 Mar 4. N Engl J Med. 2016. PMID: 26943128 Free article. Clinical Trial.
A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries.
Bhasin S, Gill TM, Reuben DB, Latham NK, Ganz DA, Greene EJ, Dziura J, Basaria S, Gurwitz JH, Dykes PC, McMahon S, Storer TW, Gazarian P, Miller ME, Travison TG, Esserman D, Carnie MB, Goehring L, Fagan M, Greenspan SL, Alexander N, Wiggins J, Ko F, Siu AL, Volpi E, Wu AW, Rich J, Waring SC, Wallace RB, Casteel C, Resnick NM, Magaziner J, Charpentier P, Lu C, Araujo K, Rajeevan H, Meng C, Allore H, Brawley BF, Eder R, McGloin JM, Skokos EA, Duncan PW, Baker D, Boult C, Correa-de-Araujo R, Peduzzi P; STRIDE Trial Investigators. Bhasin S, et al. N Engl J Med. 2020 Jul 9;383(2):129-140. doi: 10.1056/NEJMoa2002183. N Engl J Med. 2020. PMID: 32640131 Free PMC article. Clinical Trial.
Nucleolar localisation of three Hox homeoproteins.
Corsetti MT, Levi G, Lancia F, Sanseverino L, Ferrini S, Boncinelli E, Corte G. Corsetti MT, et al. J Cell Sci. 1995 Jan;108 ( Pt 1):187-93. doi: 10.1242/jcs.108.1.187. J Cell Sci. 1995. PMID: 7738096
Purified nucleoli from stimulated T lymphocytes, and Raji cells contain an activity capable of binding, in a gel retardation assay, to an oligonucleotide specifically recognised by the HOXD4 homeoprotein. This activity is specifically removed by anti-HOXD4 antibodies and i …
Purified nucleoli from stimulated T lymphocytes, and Raji cells contain an activity capable of binding, in a gel retardation assay, t …
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteins.
Frederick MJ, Rodriguez LV, Johnston DA, Grimm EA. Frederick MJ, et al. Cancer Res. 1996 Jan 1;56(1):127-37. Cancer Res. 1996. PMID: 8548752
Exposure to either SK-Mel-1 (melanoma) or Raji (lymphoma) targets led to increased phosphorylation of two M(r) 65,000 LAK proteins, pp65a and pp65b, with isoelectric points of 5.1 and 5.2, respectively. ...
Exposure to either SK-Mel-1 (melanoma) or Raji (lymphoma) targets led to increased phosphorylation of two M(r) 65,000 L …
Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis.
Guan E, Robinson SL, Goodman EB, Tenner AJ. Guan E, et al. J Immunol. 1994 Apr 15;152(8):4005-16. J Immunol. 1994. PMID: 8144968
Immunoprecipitation followed by Western blot analysis demonstrated that three mAbs, designated R139 (IgG2b), R3 (IgM), and U40.3 (IgG1), recognize the same 100,000 M(r) protein (126,000 M(r) under reducing conditions). These mAbs also co-immunoprecipit …
Immunoprecipitation followed by Western blot analysis demonstrated that three mAbs, designated R139 (IgG2b), R3 (IgM), and U40.3 (IgG1), rec …
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin.
Frederick MJ, Rodriguez LV, Johnston DA, Darnay BG, Grimm EA. Frederick MJ, et al. Cancer Res. 1996 Jan 1;56(1):138-44. Cancer Res. 1996. PMID: 8548753
Contact between lymphokine-activated killer (LAK) cells and natural killer-resistant tumor targets SK-Mel-1 (human melanoma) or Raji (human lymphoma) stimulates phosphorylation of two M(r) 65,000 LAK proteins (pp65a and pp65b) with nearly identical isoelectri …
Contact between lymphokine-activated killer (LAK) cells and natural killer-resistant tumor targets SK-Mel-1 (human melanoma) or Raji …
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, Lamborn KR, O'Donnell RT, DeNardo GL. DeNardo SJ, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3854S-64S. Clin Cancer Res. 2003. PMID: 14506183
We used branched poly(ethylene glycol) (pegylated) polymers (M(r) 40,000, M(r) 70,000, M(r) 100,000, and M(r) 150,000) conjugated to tumor-specific and control peptides to assess the effect of both molecular weight and tumor …
We used branched poly(ethylene glycol) (pegylated) polymers (M(r) 40,000, M(r) 70,000, M(r) 100,00 …
Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.
WHO ACTION Trials Collaborators; Oladapo OT, Vogel JP, Piaggio G, Nguyen MH, Althabe F, Gülmezoglu AM, Bahl R, Rao SPN, De Costa A, Gupta S, Baqui AH, Khanam R, Shahidullah M, Chowdhury SB, Ahmed S, Begum N, D Roy A, Shahed MA, Jaben IA, Yasmin F, Rahman MM, Ara A, Khatoon S, Ara G, Akter S, Akhter N, Dey PR, Sabur MA, Azad MT, Choudhury SF, Matin MA, Goudar SS, Dhaded SM, Metgud MC, Pujar YV, Somannavar MS, Vernekar SS, Herekar VR, Bidri SR, Mathapati SS, Patil PG, Patil MM, Gudadinni MR, Bijapure HR, Mallapur AA, Katageri GM, Chikkamath SB, Yelamali BC, Pol RR, Misra SS, Das L, Nanda S, Nayak RB, Singh B, Qureshi Z, Were F, Osoti A, Gwako G, Laving A, Kinuthia J, Mohamed H, Aliyan N, Barassa A, Kibaru E, Mbuga M, Thuranira L, Githua NJ, Lusweti B, Ayede AI, Falade AG, Adesina OA, Agunloye AM, Iyiola OO, Sanni W, Ejinkeonye IK, Idris HA, Okoli CV, Irinyenikan TA, Olubosede OA, Bello O, Omololu OM, Olutekunbi OA, Akintan AL, Owa OO, Oluwafemi RO, Eniowo IP, Fabamwo AO, Disu EA, Agbara JO, Adejuyigbe EA, Kuti O, Anyabolu HC, Awowole IO, Fehintola AO, Kuti BP, Isah AD, Olateju EK, Abiodun O, Dedeke OF, Akinkunmi FB, Oyeneyin L, Adesiyun O, Raji HO, Ande ABA, Okonkwo I, Ariff S, Soof… See abstract for full author list ➔ WHO ACTION Trials Collaborators, et al. N Engl J Med. 2020 Dec 24;383(26):2514-2525. doi: 10.1056/NEJMoa2022398. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33095526 Free PMC article. Clinical Trial.
19 results